- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00173121
Environmental Enterovirus Monitoring
12. september 2005 oppdatert av: National Taiwan University Hospital
From last decades, because of lacking the powerful quantitative methods, such as real-time qPCR, there is no environmental monitoring data about enterovirus transmission.
If the major transmission routes and risk factor are still not clear, it will be very hard for making the prevention and control strategies.
Today, the most popular prevention suggestion for children is keeping them away from crowded public places during the peak contagious season, because enteroviruses are easily transmitted through aerosols over a distance of meters, and even between separated rooms (Chang et al., 2004).
However, adults may as easily be infected, but don』t have any disease symptoms or carry the virus home.
Another recommendation is washing hands to avoid contact of hands or anything else with the mouth and nose, as it is through contact of viruses with the mucosal membranes in the mouth and nasal passages that infection occurs.
However, these actions did not be great helpful for preventing enterovirus infection and spread.
Understanding and disrupting the major transmission pass way of enterovirus could be more effective than just keeping personal hygiene.
Therefore, an applicable environmental monitoring program is needed for understanding the transmission routes and risk factor of enterovirus infection.
In this study, we will monitor enteroviruses in hospital, household and kindergarten.
For the environmental monitoring of enteroviruses, we will apply traditional plaque assay, real-time quantitative PCR and combine with questionnaire-based interviews to understand the infectious types and concentration of enterovirus from indoor air, surface and water for recognizing the transmission routes of enterovirus and the relationships between virus concentration and the symptoms of the cases.
Studieoversikt
Status
Ukjent
Forhold
Detaljert beskrivelse
Environmental Monitoring Program for Enterovirus (1) Case Collection.
The studies cases include patients who were suspected of having enterovirus illnesses, such as HFMD and herpangina.
Institutional review board approval was obtained from the Hospital for this study and informed consent was obtained from all patients or their parents.
(2) Questionnaire.
questionnaire based interviews were used to collect information about the family members, including demographic data, the number of bedrooms in the house, amount of contact time with the patient, presence and pattern of current or recent signs and symptoms.
(3) Patient and culture samples.
Laboratory evidence of enterovirus infection was defined as the isolation of enterovirus from a throat , and rectal swab sample.
(4) Environmental Sampling.
(a) Air sampling.
For the filter/real-time qPCR assay, the air in each ward was filtered through a 37-mm-diameter Nuclepore filter (Costar, Cambridge, MA), which is a track-etched polycarbonate filter consisting of a polycarbonate membrane with straight-through pores of uniform size (0.4 μm).
The filters were supported by cellulose pads and loaded into open-face three-piece plastic cassettes.
The pump and filter apparatus were placed within 1 m from the patient's bed on an adjacent nightstand.
(b) Surface sampling Regarding surface sampling, surfaces of environment and equipment were sampled with moistened sterile cotton swabs.
Studietype
Observasjonsmessig
Registrering
50
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Luan-Yin Chang, MD
- Telefonnummer: 3245 886-2-23123456
- E-post: ly7077@tpts6.seed.net.tw
Studiesteder
-
-
-
Taipei, Taiwan, 100
- Rekruttering
- National Taiwan University Hsopital
-
Ta kontakt med:
- Luan-Yin Chang, MD, PhD
- E-post: ly7077@tpts6.seed.net.tw
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
1 uke til 18 år (Barn, Voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- any case of enterovirus infection
Exclusion Criteria:
- not enterovirus infection cases
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Etterforskere
- Hovedetterforsker: Luan-Yin Chang Chang, MD, PhD, National Taiwan University Hospital
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. mai 2005
Studiet fullført
1. juni 2005
Datoer for studieregistrering
Først innsendt
12. september 2005
Først innsendt som oppfylte QC-kriteriene
12. september 2005
Først lagt ut (Anslag)
15. september 2005
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
15. september 2005
Siste oppdatering sendt inn som oppfylte QC-kriteriene
12. september 2005
Sist bekreftet
1. april 2005
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 9461700414
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Transmission Condition
-
University of IowaKenall ManufacturingTilbaketrukketBakteriell overføring | S.Aureus Transmission | Operasjonsromseksponering for S. Aureus | 90-dagers postoperative kirurgiske infeksjoner, overfladiske og dypeForente stater